Jindi Ma

Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling

Jiansheng Li, Jindi Ma, Yange Tian et al. · Journal of Ethnopharmacology · 2020 · 55 citations · Full text

Medicine, Endocrinology, Pharmacology +11

Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease

Jiansheng Li, Xuefang Liu, Haoran Dong et al. · Journal of Integrative Medicine · 2020 · 33 citations · Full text

Medicine, Pharmaceutical Analysis, Pharmacology +10

Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-<i>κ</i>B Signaling

Jindi Ma, Yange Tian, Jiansheng Li et al. · Evidence-based Complementary and Alternative Medicine · 2019 · 22 citations · Full text

Medicine, Immunology, Pharmacology +17

Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling

Kexin Xu, Jindi Ma, Ruilong Lu et al. · Bioscience Reports · 2023 · 17 citations · Full text

Medicine, Pharmacology, Rehabilitation Medicine +15

Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway

Jindi Ma, Xuefang Liu, Yumeng Wei et al. · Evidence-based Complementary and Alternative Medicine · 2022 · 14 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17